Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
liquidation
Biotech
SQZ opts for liquidation, $11.8M asset fire sale to Stemcell
SQZ’s shareholders have opted to begin the process of liquidating and selling off what remains of the company's assets to Stemcell for $11.8 million.
James Waldron
Mar 1, 2024 10:20am
The unraveling of EQRx's low-cost drug dream
Oct 5, 2023 10:47am
Fresh Tracks to dissolve after hunt for buyer comes up empty
Sep 19, 2023 5:37pm
Cash-strapped Calithera closes down in wake of enrollment delays
Jan 10, 2023 8:05am